• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有骨骼肌转移的颊黏膜鳞状细胞癌中的难治性恶性肿瘤高钙血症

Refractory Hypercalcemia of Malignancy in Squamous Cell Carcinoma of the Buccal Mucosa With Skeletal Muscle Metastasis.

作者信息

Reddy Bana Sai Krishna, Dhadwad Jagannath S, Modi Kunal, Roushan Kumar, Kulkarni Prabhanjan, Dash Chandan

机构信息

Internal Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.

出版信息

Cureus. 2024 Oct 18;16(10):e71816. doi: 10.7759/cureus.71816. eCollection 2024 Oct.

DOI:10.7759/cureus.71816
PMID:39559636
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11570781/
Abstract

Refractory hypercalcemia of malignancy (RHOM) is a challenging and often life-threatening condition characterized by persistently high serum calcium levels despite standard treatments. It is commonly associated with malignancies such as squamous cell carcinoma (SCC) of the lung, breast cancer, and multiple myeloma. However, studies on head and neck cancers, including SCC of the oral cavity, suggest that hypercalcemia can occur but is relatively rare. We report a case of a 45-year-old male with SCC of the buccal mucosa who presented with severe, refractory hypercalcemia. Despite aggressive hydration, bisphosphonates, calcitonin therapy, and glucocorticoids, serum calcium levels remained elevated. The patient was subsequently treated with hemodialysis, but despite this intervention, his clinical status did not improve, ultimately leading to his mortality. This case highlights the challenges in managing RHOM and underscores the need for better therapeutic strategies. Timely recognition and innovative treatment approaches are crucial for improving patient outcomes in refractory cases of hypercalcemia of malignancy.

摘要

恶性肿瘤难治性高钙血症(RHOM)是一种具有挑战性且往往危及生命的病症,其特征是尽管进行了标准治疗,但血清钙水平持续居高不下。它通常与肺癌、乳腺癌和多发性骨髓瘤等恶性肿瘤相关。然而,包括口腔鳞状细胞癌(SCC)在内的头颈部癌症研究表明,高钙血症虽可发生,但相对罕见。我们报告一例45岁男性颊黏膜鳞状细胞癌患者,该患者出现严重的难治性高钙血症。尽管进行了积极的补液、双膦酸盐、降钙素治疗和糖皮质激素治疗,血清钙水平仍居高不下。该患者随后接受了血液透析治疗,但尽管采取了这一干预措施,其临床状况并未改善,最终导致死亡。该病例凸显了管理RHOM的挑战,并强调了需要更好的治疗策略。及时识别和创新治疗方法对于改善恶性肿瘤高钙血症难治性病例的患者预后至关重要。

相似文献

1
Refractory Hypercalcemia of Malignancy in Squamous Cell Carcinoma of the Buccal Mucosa With Skeletal Muscle Metastasis.伴有骨骼肌转移的颊黏膜鳞状细胞癌中的难治性恶性肿瘤高钙血症
Cureus. 2024 Oct 18;16(10):e71816. doi: 10.7759/cureus.71816. eCollection 2024 Oct.
2
Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.神经内分泌癌作为恶性肿瘤所致体液性高钙血症的病因:一例甲状旁腺激素相关蛋白升高患者的病例
Cureus. 2022 Mar 22;14(3):e23398. doi: 10.7759/cureus.23398. eCollection 2022 Mar.
3
A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.一例难治性恶性肿瘤高钙血症及一种建议的治疗算法。
Ann Pharmacother. 2009 Sep;43(9):1532-8. doi: 10.1345/aph.1L313. Epub 2009 Jul 21.
4
Hypercalcemic complication in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者的高钙血症并发症
Int J Oral Maxillofac Surg. 2003 Apr;32(2):174-80. doi: 10.1054/ijom.2002.0261.
5
Hypercalcemia of malignancy and new treatment options.恶性肿瘤高钙血症及新的治疗选择。
Ther Clin Risk Manag. 2015 Dec 4;11:1779-88. doi: 10.2147/TCRM.S83681. eCollection 2015.
6
Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa.地诺单抗治疗大疱性表皮松解症皮肤鳞状细胞癌继发的难治性高钙血症
World J Oncol. 2015 Apr;6(2):345-348. doi: 10.14740/wjon907w. Epub 2015 Apr 12.
7
Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis.高钙血症危象经及时无钙血液透析治疗成功。
Am J Emerg Med. 2009 Nov;27(9):1174.e1-3. doi: 10.1016/j.ajem.2009.01.026.
8
[Refractory hypercalcemia in patient with lung cancer].[肺癌患者的难治性高钙血症]
Pol Merkur Lekarski. 2014 Apr;36(214):261-4.
9
Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.慢性淋巴细胞白血病合并非小细胞肺癌患者的重度高钙血症:一例报告。
Medicine (Baltimore). 2021 Apr 9;100(14):e24982. doi: 10.1097/MD.0000000000024982.
10
Squamous Cell Carcinoma (Marjolin's Ulcer) Arising in a Sacral Decubitus Ulcer Resulting in Humoral Hypercalcemia of Malignancy.骶部压疮引发的鳞状细胞癌(Marjolin溃疡)导致恶性肿瘤体液性高钙血症。
Case Rep Med. 2014;2014:715809. doi: 10.1155/2014/715809. Epub 2014 Aug 13.

引用本文的文献

1
Exploring a Rare Association: Systematic Review of Hypercalcemia in Nontuberculous Mycobacterial Infections.探索一种罕见关联:非结核分枝杆菌感染中高钙血症的系统评价
Microorganisms. 2025 Mar 28;13(4):773. doi: 10.3390/microorganisms13040773.

本文引用的文献

1
Endocrine Society Hypercalcemia of Malignancy Guidelines.内分泌学会恶性肿瘤相关性高钙血症指南。
JAMA Oncol. 2023 Mar 1;9(3):430-431. doi: 10.1001/jamaoncol.2022.7941.
2
Parathyroid hormone-related protein (PTHrP) and malignancy.甲状旁腺激素相关蛋白(PTHrP)与恶性肿瘤
Vitam Horm. 2022;120:133-177. doi: 10.1016/bs.vh.2022.03.002. Epub 2022 Jul 25.
3
Treatment of Hypercalcemia of Malignancy.恶性肿瘤高钙血症的治疗
Endocrinol Metab Clin North Am. 2021 Dec;50(4):781-792. doi: 10.1016/j.ecl.2021.08.002.
4
Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.血钙升高与实体瘤恶性肿瘤难治性高钙血症风险增加相关。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1115-23. doi: 10.1210/clinem/dgz278.
5
Hypercalcemia of malignancy treated with cinacalcet.用西那卡塞治疗的恶性肿瘤高钙血症
Endocrinol Diabetes Metab Case Rep. 2017 Dec 15;2017. doi: 10.1530/EDM-17-0118. eCollection 2017.
6
Denosumab for treatment of hypercalcemia of malignancy.地诺单抗用于治疗恶性肿瘤引起的高钙血症。
J Clin Endocrinol Metab. 2014 Sep;99(9):3144-52. doi: 10.1210/jc.2014-1001. Epub 2014 Jun 10.
7
Imaging of the skeletal muscle metastases.骨骼肌肉转移瘤的影像学表现。
Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2057-63.
8
Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis.鳞状细胞恶性肿瘤相关性高钙血症:生存和预后因素分析。
Int J Oral Maxillofac Surg. 2011 Sep;40(9):938-42. doi: 10.1016/j.ijom.2010.11.028. Epub 2011 Apr 12.
9
Management of the adverse effects associated with intravenous bisphosphonates.静脉注射双膦酸盐相关不良反应的管理
Ann Oncol. 2006 Jun;17(6):897-907. doi: 10.1093/annonc/mdj105. Epub 2006 Mar 17.
10
Parathyroid hormone-related protein localization in breast cancers predict improved prognosis.甲状旁腺激素相关蛋白在乳腺癌中的定位预示着预后改善。
Cancer Res. 2006 Feb 15;66(4):2250-6. doi: 10.1158/0008-5472.CAN-05-2814.